Factors associated with symptoms of depression and anxiety in Mexican patients with breast cancer
Main Article Content
Abstract
Depression and anxiety are the most common psychopathologies in women with breast cancer, which increase the risk of adverse clinical outcomes and affect the cost and effectiveness of medical treatments. The objective of this work was to identify sociodemographic and psychological factors (cognitive distortions, perceived disability) associated with symptoms of depression and anxiety in a sample of Mexican patients with breast cancer.
Four psychological instruments were applied to 291 patients diagnosed with breast cancer (Beck Anxiety and Depression Inventory, Perceived Disability Evaluation Scale, and Cognitive Distortion Inventory). A bivariate and multivariate logistic regression analysis was performed.
In depressed patients there were more cases of smoking, use of medications, more cases with primary studies and fewer economically active patients. The patients with anxiety had more current smoking, more cases without studies or only primary studies and were not economically active. Taking medications, not being economically active and having only primary school or without studies are factors associated independently to depressive symptoms and, with the exception of taking medication, also to anxiety. Cognitive distortions and perceived disability explain independently the symptoms of anxiety and depression. The symptoms of depression and anxiety correlated positively with each other and with cognitive distortions and disability.
Sociodemographic factors and other psychological aspects are associated independently to the symptoms of depression and anxiety in patients with breast cancer. These factors could be considered in the design of interventions to reduce these symptoms.
Article Details
Citas en Dimensions Service
References
Alcalar, N., Ozkan, S., Kucucuk, S., Aslay, I., & Ozkan, M. (2012). Association of coping style, cognitive errors and cancer-related variables with depression in women treated for breast cancer. Jpn.J.Clin.Oncol., 42(10), 940-947. doi:10.1093/jjco/hys119
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. J.Consult Clin.Psychol., 56(6), 893-897.
Beck, A. (2006). Inventario de Depresión de Beck (BDI-II1). USA: Traducción y adaptación al castellano por Brenlla,ME(1) y The Psychological Corporation,Eds. doi:PMID: 3985195
Bender, C. M., Gentry, A. L., Brufsky, A. M., Casillo, F. E., Cohen, S. M., Dailey, M. M., … & Sherwood, P. R. (2014). Influence of patient and treatment factors on adherence to adjuvant endocrine therapy in breast cancer. Oncol.Nurs.Forum, 41(3), 274-285.
Burgess, C., Cornelius, V., Love, S., Graham, J., Richards, M., & Ramirez, A. (2005). Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ, 330(7493), 702. doi:10.1136/bmj.38343.670868.D3
Citrin, D. L., Bloom, D. L., Grutsch, J. F., Mortensen, S. J., & Lis, C. G. (2012). Beliefs and perceptions of women with newly diagnosed breast cancer who refused conventional treatment in favor of alternative therapies. Oncologist., 17(5), 607-612. doi:10.1634/theoncologist.2011-0468
Den Oudsten, B. L., Van Heck, G. L., Van der Steeg, A. F., Roukema, J. A., & De Vries, J. (2009). Predictors of depressive symptoms 12 months after surgical treatment of early-stage breast cancer. Psychooncology., 18(11), 1230-1237. doi:10.1002/pon.1518
Drost, J., Van der Does, W., van Hemert, A. M., Penninx, B. W., & Spinhoven, P. (2014). Repetitive negative thinking as a transdiagnostic factor in depression and anxiety: A conceptual replication. Behav.Res.Ther., 63C, 177-183. doi:10.1016/j.brat.2014.06.004
Eccles, S. A., Aboagye, E. O., Ali, S., Anderson, A. S., Armes, J., Berditchevski, F., ... & Bundred, N. J. (2013). Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res., 15(5), R92. doi:10.1186/bcr3493
Falagas, M. E., Zarkadoulia, E. A., Ioannidou, E. N., Peppas, G., Christodoulou, C., & Rafailidis, P. I. (2007). The effect of psychosocial factors on breast cancer outcome: A systematic review. Breast Cancer Res., 9(4), R44. doi:10.1186/bcr1744
Galindo-Vázquez, O., Rojas, E., Meneses, A., Aguilar, J., Álvarez, M., & Alvarado, S. (2015). Propiedades psicométricas del Inventario de Ansiedad de Beck (BAI) en pacientes con cáncer. Psicooncología, 12(1), 51-58. doi:10.5209/rev_PSIC.2015.v12.n1.48903
Hedayati, S. S., Bosworth, H. B., Kuchibhatla, M., Kimmel, P. L., & Szczech, L. A. (2006). The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int, 69(9), 1662-1668.
Instituto Nacional de Estadística y Geografía INEGI. (2015). Mujeres y hombres en México 2014 INEGI. Recuperado de http://www.inmujeres.gob.mx/inmujeres/images/frontpage/redes_sociales/myh_2014.pdf
Jurado, S., Villegas, M., Méndez, L., Rodríguez, F., Loperena, V., & Varela, R. (1998). La estandarización del Inventario de Depresión de Beck para residentes de la Ciudad de México. Salud Mental, 21(3), 26-31.
Kaminska, M., Kubiatowski, T., Ciszewski, T., Czarnocki, K. J., Makara-Studzińska, M., Bojar, I., & Staroslawska, E. (2015). Evaluation of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy. Ann.Agric.Environ.Med., 22(1), 185-189.
Karakoyun-Celik, O., Gorken, I., Sahin, S., Orcin, E., Alanyali, H., & Kinay, M. (2010). Depression and anxiety levels in woman under follow-up for breast cancer: Relationship to coping with cancer and quality of life. Med.Oncol., 27(1), 108-113. doi:10.1007/s12032-009-9181-4
Kertz, S. J., Koran, J., Stevens, K. T., & Bjorgvinsson, T. (2015). Repetitive negative thinking predicts depression and anxiety symptom improvement during brief cognitive behavioral therapy. Behav.Res.Ther., 68, 54-63.
Knaul, F. M., Nigenda, G., Lozano, R., Arreola-Ornelas, H., Langer, A., & Frenk, J. (2009). Breast cancer in Mexico: an urgent priority. Salud Publica Mex, 51 Suppl 2, s335-s344.
Lerma, A., Salazar, E., Perez-Grovas, H., Bermudez, L., Gutierrez, D., Reyes-Lagunes, I., … & Lerma, C. (2012). Desarrollo y validación de un instrumento para la evaluación de distorsiones cognitivas en pacientes con insuficiencia renal crónica terminal. Salud Mental, 35(3), 189-194.
Lim, C. C., Devi, M. K., & Ang, E. (2011). Anxiety in women with breast cancer undergoing treatment: a systematic review. Int J.Evid.Based.Healthc., 9(3), 215-235. doi:10.1111/j.1744-1609.2011.00221.x
Lueboonthavatchai, P. (2007). Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J.Med.Assoc.Thai., 90(10), 2164-2174.
Maass, S. W., Roorda, C., Berendsen, A. J., Verhaak, P. F., & de Bock, G. H. (2015). The prevalence of long-term symptoms of depression and anxiety after breast cancer treatment: A systematic review. Maturitas, 82(1), 100-108. doi:10.1016/j.maturitas.2015.04.010
National Cancer Institute. (2015). USA: National Cancer Institute. Recuperado de http://seer.cancer.gov/statfacts/html/breast.html
Nunnally, J. (2015). Teoría Psicométrica. México: Trillas
Organización Mundial de la Salud. (2015). Medición de la salud y la discapacidad: manual para el cuestionario de evaluación de la discapacidad (1). Suiza: OMS.
Organización Panamericana de la Salud OPS. (2015). Cáncer de mama. Recuperado de http://www.paho.org/hq/index.php?option=com_content&view=category&layout=blog&id=3400&Itemid=3639&lang=es
Ornelas-Mejorada, R. E., Tufiño Tufiño, M. A., & Sánchez-Sosa, J. J. (2011). Ansiedad y depresión en mujeres con cáncer de mama en radioterapia: prevalencia y factores asociados. Acta de Investigación Psicológica, 1(3), 401-414.
Pintado-Cucarella, S. (2016). Alteraciones de la autoestima y la imagen corporal y síntomas de depresión y ansiedad en una muestra de pacientes mexicanas con cáncer de mama. Salud Publica Mex, 58(4), 400-401.
Reich, M., Lesur, A., & Perdrizet-Chevallier, C. (2008). Depression, quality of life and breast cancer: A review of the literature. Breast Cancer Res Treat,(110), 9-17. doi:DOI 10.1007/s10549-007-9706-5
Robles, R., Morales, M., Jiménez, L., & Morales, J. (2009). Depresion y ansiedad en mujeres con cáncer de mama: el papel de la afectividad y el soporte social. Psicooncología, 6(1), 191-201.
Robles, R., Varela, R., Jurado, S., & Páez, F. (2001). Versión mexicana del Inventario de Ansiedad de Beck: propiedades psicométricas. Revista Mexicana de Psicología, 8, 211-217.
Secretaria de Salud. (2011). Perfil epidemiológico de los tumores malignos en México. Recuperado de http://www.epidemiologia.salud.gob.mx/doctos/infoepid/publicaciones/2011/monografias/P_EPI_DE_LOS_TUMORES_MALIGNOS_M%C3%A9xico.pdf
Simon, G. E., Von Korff, M., & Lin, E. (2005). Clinical and functional outcomes of depression treatment in patients with and without chronic medical illness. Psychol.Med., 35(2), 271-279.
Spinhoven, P., Drost, J., van Hemert, B., & Penninx, B. W. (2015). Common rather than unique aspects of repetitive negative thinking are related to depressive and anxiety disorders and symptoms. J.Anxiety.Disord., 33, 45-52. doi:10.1016/j.janxdis.2015.05.001
Thompson, T., Rodebaugh, T. L., Perez, M., Schootman, M., & Jeffe, D. B. (2013). Perceived social support change in patients with early stage breast cancer and controls. Health Psychol, 32(8), 886-895.
Torres-Castillo, M., Hernández-Malpica, E., & Ortega-Soto, H. (2012). Validez y reproducibilidad del Inventario para Depresión de Beck en un hospital de cardiología. Salud Mental, 14(2), 1-6.
Vahdaninia, M., Omidvari, S., & Montazeri, A. (2010). What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc.Psychiatry Psychiatr.Epidemiol., 45(3), 355-361. doi:10.1007/s00127-009-0068-7
World Health Organization. (2011a). Global status report on noncommunicable diseases 2010 (1). Geneva, Switzerland: World Health Organization. Recuperado de http://www.who.int/nmh/publications/ncd_report_full_en.pdf?ua=1
World Health Organization. (2011b). WHO Disability Assessment Schedule 2.0 WHODAS 2.0. http://www.who.int/classifications/icf/whodasii/en/#,(2).
World Health Organization. (2015). Global status report on noncommunicable diseases 2014 Switzerland: World Health Organization. Recuperado de http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1
Este obra cuyo autor es Universidad Nacional Autónoma de México está bajo una licencia de Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional de Creative Commons.
Creado a partir de la obra en http://www.revistas.unam.mx/index.php/rlmc.